Healthcare - Biotechnology - NASDAQ - IL
$ 2.23
1.36 %
$ 156 M
Market Cap
-5.57
P/E
Price Target
Average
213.90%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
-0.00%
Net Income
Estimate
25.44%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alpha Tau Medical Ltd.
Wall Street analysts predict an average 1-year price target for DRTS of $7 , with forecasts ranging from a low of $7 to a high of $7 .
DRTS Lowest Price Target
Wall Street Target
7 USD
213.90%
DRTS Average Price Target
Wall Street Target
7 USD
213.90%
DRTS Highest Price Target
Wall Street Target
7 USD
213.90%
REVENUE FORECAST
Revenue Forecast Chart DRTS
EBIT FORECAST
EBIT Forecast Chart DRTS
NET INCOME FORECAST
Net Income Chart DRTS